AP-1 in particular has been suggested to regulate Gfap elevation in different injury models [31], including a transgenic mouse model of AxD that overexpresses wild-type human GFAP [7], but whether AP-1 or other factors contribute to Gfap elevation in Gfap+R236H mice has not yet been tested. The gene discussed is GFAP; the disease is Alexander disease.